Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Terminated 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 2Rheumatoid Arthritis, Systemic Juvenile 1Periodic Fevers Syndrome 1Mevalonate Kinase Deficiency 1Metastatic Pancreatic Ductal Adenocarcinoma 1Melanoma 1Cryopyrin-Associated Periodic Syndromes 1Carcinoma 1Bronchiolitis Obliterans Syndrome 1Arthritis, Juvenile 1Arthralgia 1

Interventions

Carboplatin 235Pemetrexed 214Paclitaxel 160Cisplatin 150pembrolizumab 145Erlotinib Hydrochloride 141Docetaxel 133Gemcitabine 94Bevacizumab 85Nivolumab 72Radiotherapy 62atezolizumab 40Radiosurgery 37Afatinib 37osimertinib 35130-nm albumin-bound paclitaxel 35Cetuximab 34durvalumab 33Ipilimumab 32Gefitinib 31Albumin-Bound Paclitaxel 29Vinorelbine 23Taxes 22Etoposide 20Crizotinib 19Radiation 17Sorafenib 16Cyclophosphamide 16Dexamethasone 15Magnetic Resonance Spectroscopy 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Carcinoma, Non-Small-Cell Lung × canakinumab × Clear all
NCT03631199 2026-02-25

CANOPY-1

Novartis

Phase 3 Terminated
673 enrolled 38 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT03447769 2024-10-09

Canopy-A

Novartis

Phase 3 Terminated
1,382 enrolled 23 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03968419 2024-06-20

CANOPY-N

Novartis

Phase 2 Terminated
88 enrolled 21 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03626545 2023-08-21

CANOPY-2

Novartis

Phase 3 Terminated
245 enrolled 29 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡